Evidence for causal effects of polycystic ovary syndrome on oxidative stress: a two-sample mendelian randomisation study
- PMID: 37337194
- PMCID: PMC10278295
- DOI: 10.1186/s12920-023-01581-0
Evidence for causal effects of polycystic ovary syndrome on oxidative stress: a two-sample mendelian randomisation study
Abstract
Background: Polycystic ovary syndrome (PCOS) is often accompanied by increased oxidative stress levels; however, it is still unclear whether PCOS itself is causally related to oxidative stress (OS), whether OS can increase the occurrence of PCOS, and which characteristics of PCOS increase OS levels. Therefore, this study explored the causal relationship between PCOS, its characteristics, and OS.
Methods: Two-sample bidirectional and two-sample Mendelian randomisation studies were performed based on publicly available statistics from genome-wide association studies. PCOS; its characteristics, such as testosterone, low-density lipoprotein, high-density lipoprotein; and 11 major OS markers (superoxide dismutase, glutathione S-transferase, glutathione peroxidase, catalase, uric acid, zinc, tocopherol, ascorbic acid, retinol, albumin, and total bilirubin), were studied. The main analytical method used was inverse variance weighting (IVW). Pleiotropy was evaluated using the Mendelian randomisation-Egger intercept. Q and P values were used to assess heterogeneity.
Results: There was no causal relationship between PCOS and the OS indices (all P > 0.05). There was a causal relationship between the OS index, ascorbate level, and PCOS (IVW, odds ratio: 2.112, 95% confidence interval: 1.257-3.549, P = 0.005). In addition, there was a causal relationship between testosterone, low-density lipoprotein, high-density lipoprotein, sex hormone-binding globulin, body mass index, triacylglycerol, age at menarche, and most OS indices according to the IVW method. The F statistics showed that there was no weak instrumental variable. A sensitivity analysis was performed using the leave-one-out method. No pleiotropy was observed. The results were robust, and the conclusions were reliable.
Conclusions: This study showed for the first time that there was no causal relationship between PCOS and OS. However, there was a causal relationship between the OS index, ascorbate level, and PCOS. It revealed that PCOS itself could not increase OS, and the increase in OS in PCOS was related to other potential factors, such as testosterone, low-density lipoprotein, high-density lipoprotein, sex hormone-binding globulin, body mass index, triacylglycerol, and age at menarche.
Keywords: Mendelian randomisation study; Oxidative stress; Polycystic ovary syndrome.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Investigating the causal impact of polycystic ovary syndrome on gestational diabetes mellitus: a two-sample Mendelian randomization study.Front Endocrinol (Lausanne). 2024 Feb 5;15:1337562. doi: 10.3389/fendo.2024.1337562. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38375192 Free PMC article.
-
Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: evidence from a comprehensive genetic analysis.Hum Reprod. 2021 Jul 19;36(8):2382-2391. doi: 10.1093/humrep/deab119. Hum Reprod. 2021. PMID: 34051085
-
Genetically predicted high sex hormone binding globulin was associated with decreased risk of polycystic ovary syndrome.BMC Womens Health. 2024 Jun 20;24(1):357. doi: 10.1186/s12905-024-03144-6. BMC Womens Health. 2024. PMID: 38902677 Free PMC article.
-
Mendelian randomization study investigating the relationship between nutrients and polycystic ovary syndrome.Int J Gynaecol Obstet. 2025 Apr;169(1):198-205. doi: 10.1002/ijgo.16029. Epub 2024 Nov 21. Int J Gynaecol Obstet. 2025. PMID: 39569763 Review.
-
Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis.J Obstet Gynaecol. 2017 Nov;37(8):1036-1047. doi: 10.1080/01443615.2017.1318840. Epub 2017 Jun 28. J Obstet Gynaecol. 2017. PMID: 28657375 Review.
Cited by
-
Reactive oxygen species in polycystic ovary syndrome: Mechanistic insights into pathogenesis and therapeutic opportunities.Redox Biol. 2025 Sep;85:103776. doi: 10.1016/j.redox.2025.103776. Epub 2025 Jul 17. Redox Biol. 2025. PMID: 40694958 Free PMC article. Review.
-
Investigating the causal impact of polycystic ovary syndrome on gestational diabetes mellitus: a two-sample Mendelian randomization study.Front Endocrinol (Lausanne). 2024 Feb 5;15:1337562. doi: 10.3389/fendo.2024.1337562. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38375192 Free PMC article.
-
Advancements in the Management of Endocrine System Disorders and Arrhythmias: A Comprehensive Narrative Review.Cureus. 2023 Oct 4;15(10):e46484. doi: 10.7759/cureus.46484. eCollection 2023 Oct. Cureus. 2023. PMID: 37927670 Free PMC article. Review.
-
Phenolic-loaded nanofiber from Arctium lappa root: a potential therapy for testosterone-induced ovarian oxidative stress.J Biol Eng. 2025 May 9;19(1):42. doi: 10.1186/s13036-025-00515-x. J Biol Eng. 2025. PMID: 40346711 Free PMC article.
-
Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: from mechanisms to therapeutic strategies.Reprod Biol Endocrinol. 2024 Dec 26;22(1):159. doi: 10.1186/s12958-024-01337-0. Reprod Biol Endocrinol. 2024. PMID: 39722030 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical